Management Board

Heike Schoen, Co-Founder and Managing Director, has worked in leading positions in clinical research for more than 20 years.  Her experience ranges from conducting national and international Phase I clinical trials all the way to registration and post‑marketing activities on behalf of contract research organizations (CROs) and the biotechnology industry.  Her previous positions also included operational management and general management.  She holds a master’s degree in psychology and a master’s degree in business administration.
Since 2002, she has been active in the Association of Clinical Research Professionals (ACRP) where she also served as a member of the Board of Trustees and as its Chair in 2010.

Myrthe Rijswijk-Trompert, Co-Founder and Member of the Management Board, has worked as a lawyer in the clinical research industry for more than 15 years, for example, as a Senior Legal Counsel for countries outside the USA on behalf of a global CRO. Since 2010, Myrthe has been the CEO and Senior Legal Consultant of Salvius Legal, a company specializing in contract management support for the clinical trial industry.
As such, she has gained a thorough understanding and knowledge of clinical trial processes and the requisite contractual and regulatory requirements for performing clinical trials in Europe and the rest of the world.

Prof. Kurt Miller, Co-Founder and Member of the Management Board, has been a Professor of Urology at the Benjamin Franklin Medical Center’s Department of Urology in Berlin, Germany, since 1993 where he has also been the Department’s Chair since that time. He has been the Chair of the Department of Urology for the entire Charité University Hospital (Campus Benjamin Franklin, Campus Mitte, and Campus Virchow Klinikum) since 2007.

Between 1998 and 2004, he was the Chair of the Association of Urological Oncology. He also was a Member of the Board of the German Urological Association between 2001 and 2003 and a Member of the Board of the German Cancer Society between 2004 and 2008. Currently, he is the Chair of the German Urological Society’s Section of Urological Oncology.
Kurt Miller has authored more than 300 publications and is the co-editor of the German Textbook of Urology.  He serves as a peer reviewer for the German Research Association and for several scientific journals. Kurt Miller has also been the principal investigator of numerous clinical trials in uro-oncology.